Nanostructured PMMA Pillars for Bactericidal Surfaces

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibiofouling materials for biomedical implants are ineffective in preventing biofilm formation, as bacteria develop resistance to antimicrobial agents and chemical surface modifications are not long-term solutions, and can be toxic, while also raising concerns about biocompatibility.

Innovation Solution

The development of a bactericidal surface with nanostructured pillars created using nanoimprint lithography on polymethylmethacrylate (PMMA) films, which prevents biofilm formation by physically inhibiting bacterial adhesion through surface nanotexture without chemical modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical surface modifications are used to prevent bacterial adhesion, then biofilm formation is inhibited, but the surface becomes toxic and biocompatibility is compromised

Engineering Contradiction:
Improvebiofilm preventionVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical modification methods with physical nanotexture modification. By creating nanopillars with specific dimensions (50-200 nm diameter, 100-500 nm height) through physical means such as electron beam lithography or self-assembly, the surface achieves bactericidal properties without introducing toxic chemicals. The mechanical interaction between bacterial cells and the nanopillar array physically disrupts bacterial membranes, eliminating the need for toxic chemical agents while maintaining biocompatibility.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If antimicrobial agents are applied to prevent bacterial proliferation, then biofilm formation is reduced, but bacteria develop resistance over time

Engineering Contradiction:
Improvebiofilm preventionVSAvoidlong-term effectiveness
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The invention substitutes chemical antimicrobial agents with a physical nanotexture system that mechanically disrupts bacterial cells. The nanopillar array (50-200 nm diameter, 100-500 nm height) creates irreversible physical damage to bacterial membranes upon contact, a mechanism that cannot induce resistance in the way bacteria develop resistance to chemical agents. This mechanical action provides sustained long-term effectiveness without the resistance development problem.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent segments the surface into numerous nanopillars (50-200 nm diameter) spaced at specific intervals (100-500 nm apart). This segmentation creates multiple discrete interaction points that collectively deliver mechanical disruption to bacterial cells. The segmented nanoscale structure provides redundant bactericidal action across the entire surface, ensuring long-term reliability even as bacterial populations change.

Inventive Principle:
Principle #1Segmentation

3Reliability

If chemical coatings are applied to inhibit cell adhesion, then initial biofilm formation is prevented, but the coating is masked by adsorbed proteins

Engineering Contradiction:
Improvecell adhesion inhibitionVSAvoiddurability
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent replaces chemical adhesion-inhibition coatings with a physical nanotexture system. The nanopillar array (50-200 nm diameter, 100-500 nm height) creates mechanical disruption that is independent of protein adsorption. Since the bactericidal mechanism is purely physical (mechanical membrane disruption) rather than chemical, adsorbed protein layers cannot mask or neutralize the effect, ensuring long-term durability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Reliability

If selenium nanoparticles are used as antibacterial coating, then bacterial growth is inhibited, but high levels of selenium are toxic to the body

Engineering Contradiction:
Improveantibacterial activityVSAvoidsystemic toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces selenium nanoparticle chemistry with pure physical nanotexture. The nanopillar structures (50-200 nm diameter, 100-500 nm height) kill bacteria through mechanical membrane disruption without releasing any toxic substances into the body. This eliminates the systemic toxicity concern associated with selenium and other metallic nanoparticle coatings while maintaining effective antibacterial activity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS10875235B2Bactericidal surface patterns
Publication Date: 2020.12.29 RGT UNIV OF CALIFORNIA
  • US10875235B2 patent drawing
  • US10875235B2 patent drawing
  • US10875235B2 patent drawing

AI summary

The invention relates to imparting surfaces with nanometer sized structures that provide bactericidal properties to the surface and devices. In one embodiment, the present invention provides a bactericidal surface with nanometer sized pillars created by imprinting a softened polymer surface with a mold. In another embodiment, the nanometer sized pillars are part of a medical device with antibacterial properties.